NARG1 Antibody

BT-AP05782

Rabbit

IgG

20ul,50ul,100ul

Polyclonal

The antiserum was produced against synthesized peptide derived from human NARG1. AA range:221-270

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

1 mg/ml

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

-20°C for one year

NAA15 is a Protein Coding gene. Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter. Diseases associated with NAA15 include n-terminal acetyltransferase deficiency and gastric cancer. Gene Ontology (GO) annotations related to this gene include poly(A) RNA binding and N-acetyltransferase activity. An important paralog of this gene is NAA16.

Human: Q9BXJ9; Mouse: Q80UM3;

101272

Human: 80155

NAA15; GA19; NARG1; NATH; TBDN100; N-alpha-acetyltransferase 15; NatA auxiliary subunit; Gastric cancer antigen Ga19; N-terminal acetyltransferase; NMDA receptor-regulated protein 1; Protein tubedown

Epigenetics and Nuclear Signaling

NAA15